Feb 23, 2017 First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals
Feb 21, 2017 PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial
Feb 13, 2017 PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity
Jan 30, 2017 PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA
